Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStopping Wegovy is a decision worth thinking through carefully. You can stop taking it at any point, but there is no clinical taper protocol required — semaglutide does not cause physical dependence. What does matter is timing, reason, and what happens next. This is a prescription-only medicine; any planned change should involve your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
From a pharmacology standpoint, yes. Semaglutide does not create the kind of physical dependence that requires a structured taper. Once you stop injecting, the medicine clears your system over several weeks, the half-life means plasma levels fall gradually even after your last dose, which is why some effects linger briefly.
What is not straightforward is the biology underneath. Wegovy works partly by dampening appetite signals that your body will reassert once the medicine is gone. The NHS medicines page for semaglutide notes that weight management medicines are typically intended for long-term use alongside lifestyle changes, not as a short course. That context matters when you are deciding whether to stop now or later.
There is also the question of why you are stopping. Unwanted side effects, cost, pregnancy planning, and reaching a stable weight are each different situations with different answers. The sections below work through the main ones.
This is the part most people want a straight answer on. The honest one: for the majority of people, stopping Wegovy leads to weight regain. The STEP 1 trial extension, published in the New England Journal of Medicine, found that participants who stopped semaglutide regained roughly two-thirds of their lost weight within a year, while those who continued maintained their results. That is a significant difference.
It does not mean stopping is wrong. It means the decision is better made with clear expectations. A useful habit before you make a final call: spend one week logging how much you are actually eating now versus before you started treatment. Many people are surprised by how much the medicine has shifted their baseline. That single data point often clarifies whether appetite has genuinely settled or is being managed entirely by the drug.
For a broader look at when stopping might genuinely be the right move, including weight-maintenance criteria, there is more detail on that page. And if you are weighing up how soon you will see results from Wegovy and whether you have given treatment enough time to judge fairly, our page on that covers the evidence in plain terms, alongside our page on how long Wegovy takes to work which gives the trial timeline in plain terms.
Nausea, fatigue, and gut discomfort prompt a lot of people to consider stopping, especially in the first few weeks or after a dose increase. These are real and can be significant. Before discontinuing entirely, it is worth knowing that a temporary pause or a return to the previous dose sometimes resolves things without losing all progress. That conversation belongs with your prescriber.
Cost is another honest reason. Wegovy is a private prescription medicine for most people in England, and the monthly expense adds up over time. If that is the driving factor, it is worth reading about how Wegovy is priced and what is typically included in a legitimate private prescription service before deciding. Cutting corners by stopping and sourcing a cheaper supply through unverified channels is a genuine safety risk; the MHRA has documented fake semaglutide pens in circulation that have caused harm.
Pregnancy, trying to conceive, or breastfeeding: stopping is the right call here, and promptly. Clinical guidance is clear that Wegovy is not recommended in these situations, and a wash-out period before trying to conceive is advised. Your prescriber will give you the specific timing. Equally, if you are about to have surgery, tell your anaesthetist and surgical team about your treatment, this is important regardless of whether you are planning to stop.
For people who stop and later want to restart, restarting Wegovy after a break is covered in detail separately, including what clinical reassessment looks like.
The practical process is simple: stop the injection on the week you decide. There is no specific titration-down required. What matters is that a clinician is involved in the decision, not just informed after the fact. They can check whether your weight-related health conditions need monitoring, whether any medicines you take alongside Wegovy need reviewing, and whether a structured plan for the period after stopping would help.
If you are a patient with nume (sorry, with our pharmacy) our prescribers review every repeat before it is dispensed, which means you have a natural point to raise this. The aftercare line is available seven days a week. If you are currently on treatment elsewhere and considering switching or stopping, the same principle applies: loop in your prescriber before the last pen, not after.
Wondering whether treatment is still right for you, or whether a different approach might fit better? Our weight-loss treatment page covers the full range of options available through a regulated UK private service, and what to expect in the weeks after stopping is covered step by step for anyone who has already made the decision.
If you are at the stage of reassessing your options rather than simply stopping, check your eligibility for a free consultation with one of our prescribers, no pressure, just a clinical conversation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.